Medpace

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.

CEO

August James Troendle

CEOAugust James Troendle

Employees

6,200

Employees6,200

Headquarters

Cincinnati, Ohio

HeadquartersCincinnati, Ohio

Founded

1992

Founded1992

Employees

6,200

Employees6,200

MEDP Key Statistics

Market cap

12.97B

Market cap12.97B

Price-Earnings ratio

28.58

Price-Earnings ratio28.58

Dividend yield

—

Dividend yield—

Average volume

271.15K

Average volume271.15K

High today

$458.00

High today$458.00

Low today

$442.95

Low today$442.95

Open price

$453.53

Open price$453.53

Volume

190.00K

Volume190.00K

52 Week high

$628.92

52 Week high$628.92

52 Week low

$294.07

52 Week low$294.07

Stock Snapshot

The current Medpace(MEDP) stock price is $454.25, with a market capitalization of 12.97B. The stock trades at a price-to-earnings (P/E) ratio of 28.58.

During the trading session on 2026-06-07, Medpace(MEDP) shares reached a daily high of $458.00 and a low of $442.95. At a current price of $454.25, the stock is +2.6% higher than the low and still -0.8% under the high.

Trading volume for Medpace(MEDP) stock has reached 190K, versus its average volume of 271.15K.

The stock's 52-week range extends from a low of $294.07 to a high of $628.92.

MEDP News

Barchart 2d

MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com

...

TipRanks 3d

Medpace Elevates Brad Hansman to Executive Operations Role

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

TipRanks 3d

BEACON Phase III Rugonersen Trial Puts Medpace in Focus for Rare Disease Investors

Medpace Holdings Inc (MEDP) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analys...

Analyst ratings

60%

of 15 ratings

Buy

33.3%

Hold

60%

Sell

6.7%

More MEDP News

Nasdaq 5d

Medpace Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest close session, Medpace (MEDP) was down 1.3% at $445.59. This change lagged the S&P 500's daily gain of 0.13%. Meanwhile, the Dow gained 0.45%, and...

TipRanks 5d

Top Medpace Insider Executes Major Multi-Million Dollar Stock Move

New insider activity at Medpace Holdings ( (MEDP) ) has taken place on June 1, 2026. Claim 55% Off TipRanks Unlock trusted, data-backed investing tools with Tip...

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.